Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company ...

The headline numbers for Medtronic (MDT) give insight into how the company performed in the quarter ended January 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Medtronic plc MDT reported adjusted earnings per share (EPS) of $1.39 for the third quarter fiscal of 2025, up 6.9% from the ...

Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

Investment analysts at Leerink Partnrs lowered their Q1 2025 earnings per share estimates for shares of Edwards Lifesciences ...

CVRx (Nasdaq:CVRX) shares took a hit today on fourth-quarter results that fell short of earnings per share expectations.

Welcome to the Genuine Parts Company Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] This call is being recorded on Tuesday, February 18, 2025. At this time, I would like to turn ...

Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for CVRx in a research report issued on Wednesday, ...

the heart of our concern, being what steps council is taking to address conflicts that arise," she said. "And then also … ensuring that we can say both to the members of EPS and to the public ...

At the heart of Archer-Daniels-Midland's operations ... Looking ahead, ADM is projecting an EPS range of $4.00 to $4.75 for 2025, reflecting an optimistic yet cautious forecast amid anticipated ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...